Hepatic cirrhosis is a serious, long-term scarring of the liver that develops after years of damage, and while the scarring itself cannot be reversed, treatment aims to slow its progression, manage symptoms, and prevent life-threatening complications that may arise when the liver begins to fail.

Understanding Treatment Goals for Liver Scarring

When someone receives a diagnosis of hepatic cirrhosis, it marks a turning point in their liver health journey. This condition represents permanent scarring that has replaced healthy liver tissue over many years of continuous injury. The main goals of treatment focus on preventing further damage, helping the liver function as well as possible, managing complications that arise, and improving the patient’s overall quality of life.^[1]

Treatment approaches depend heavily on what originally caused the liver damage, how far the disease has progressed, and the individual patient’s overall health. In the early stages, known as compensated cirrhosis, the body can still work around the damage and many people feel relatively well. As the condition advances to decompensated cirrhosis, serious complications develop and treatment becomes more complex.^[1]

Medical societies and liver specialists have developed standard treatment guidelines based on years of research and clinical experience. At the same time, researchers around the world are testing new therapies in clinical trials, searching for better ways to help people living with this condition. The path forward involves both proven treatments and promising experimental approaches that may one day become standard care.^[1]

Standard Treatment Approaches

The foundation of treating hepatic cirrhosis starts with addressing whatever caused the liver damage in the first place. For people whose cirrhosis developed from heavy alcohol use, complete abstinence from alcohol is essential. Even small amounts can accelerate liver damage. Healthcare providers often refer patients to alcohol treatment programs and counseling services to help them stop drinking and stay sober.^[12]

When chronic hepatitis C virus infection is the culprit, doctors prescribe antiviral medicines that directly attack the virus. These modern medications, known as direct-acting antivirals, have revolutionized hepatitis C treatment. Studies show they can cure more than 95% of people with chronic hepatitis C in just 8 to 12 weeks. Curing the hepatitis C infection stops further liver damage, though it does not reverse existing scarring.^[12]

For chronic hepatitis B infection, which cannot be cured but can be controlled, doctors prescribe antiviral medicines that slow or stop the virus from causing additional liver damage. These medications must typically be taken long-term to keep the virus suppressed and protect the liver from further harm.^[12]

People whose cirrhosis stems from metabolic dysfunction-associated steatohepatitis, or MASH (formerly called nonalcoholic steatohepatitis), need a different approach. This condition involves excess fat in the liver related to metabolic problems like high blood lipids, blood sugar, and blood pressure. Treatment focuses on weight loss through healthy eating and regular physical activity. Even modest weight loss, around 5-10% of body weight, can reduce liver fat and inflammation. Some patients may benefit from additional weight-loss treatments including certain medications or, in select cases, weight-loss surgery.^[12]

When autoimmune processes cause cirrhosis, doctors use medicines that suppress or decrease the activity of the immune system. These medications help stop the body from attacking its own liver tissue, preventing further damage.^[12]

Managing Complications

As cirrhosis progresses, various complications can develop that require specific treatments. One common problem is ascites, which is fluid buildup in the abdomen. Doctors typically start by recommending a low-sodium diet, limiting salt intake to less than 2 grams per day. When dietary changes alone are not enough, they prescribe diuretic medications that help the body eliminate excess fluid through urine. These medicines make patients urinate more frequently but effectively reduce the uncomfortable swelling.^[13]

Another serious complication involves enlarged veins in the esophagus or stomach, called varices, which can bleed dangerously. To prevent bleeding, doctors often prescribe beta-blocker medications that reduce blood pressure in these vessels. If varices do bleed, emergency treatment may include medications, endoscopic procedures to stop the bleeding, or a procedure called TIPS (transjugular intrahepatic portosystemic shunt) that creates a new pathway for blood flow in the liver.^[13]

Hepatic encephalopathy is a condition where toxins that the damaged liver cannot filter properly affect brain function, causing confusion, difficulty concentrating, or changes in behavior. The main treatment is a laxative medicine called lactulose that helps remove toxins from the body. Patients typically take this medication daily, and the dose is adjusted to produce 2-3 soft bowel movements per day.^[13]

People with cirrhosis are more vulnerable to infections. Doctors may prescribe antibiotics to treat infections when they occur or, in some cases, to prevent certain types of infections from developing. Staying up to date with vaccinations, including flu shots and pneumococcal vaccines, is strongly recommended.^[13]

Nutritional Support and Lifestyle Changes

Proper nutrition plays a crucial role in managing cirrhosis. Many people with advanced liver disease do not get enough nutrients, a condition called malnutrition. Around 2 in 10 people with compensated cirrhosis are malnourished, but this increases to more than 5 in 10 people with decompensated cirrhosis. Healthcare providers often refer patients to a dietitian who specializes in liver disease.^[17]

Patients are typically advised to eat small, frequent meals throughout the day rather than three large meals. This “little and often” approach helps maintain energy levels and prevents the body from breaking down muscle for fuel. Getting enough protein is important to prevent muscle wasting, and protein can come from lean sources like beans, lentils, fish, or chicken. Despite old myths, protein restriction is rarely necessary and can actually be harmful for most cirrhosis patients.^[17]

Reducing salt intake is essential for managing fluid retention. Patients should limit total salt intake to less than 2 grams per day, which means avoiding processed foods, not adding salt to meals, and reading food labels carefully. Regular physical activity, tailored to each person’s abilities, helps maintain muscle mass and overall health.^[17]

Medication Safety

People with cirrhosis must be extremely careful about medications because the damaged liver processes drugs differently. Over-the-counter pain relievers like ibuprofen and naproxen (nonsteroidal anti-inflammatory drugs) should be avoided because they can damage the kidneys when the liver is scarred. Narcotic pain medications like oxycodone can worsen hepatic encephalopathy. Acetaminophen (also called paracetamol) can be used safely for pain relief but only in smaller doses, typically up to 2 grams per day, which equals four extra-strength tablets in a 24-hour period.^[10]

Before taking any medication, including herbal medicines and supplements, patients should check with their doctor or pharmacist. Many substances that seem harmless can interact with liver disease or prescribed medications. Some herbal products can even cause additional liver damage.^[13]

Liver Transplantation

When cirrhosis becomes very severe and the liver can no longer function adequately despite all other treatments, liver transplantation may be considered. A transplant involves surgically replacing the diseased liver with a healthy liver from a deceased donor or, less commonly, a portion of liver from a living donor. Transplantation is a major procedure with significant risks, but it can add many years to life expectancy for carefully selected patients.^[13]

Doctors use scoring systems like the MELD score (Model for End-stage Liver Disease) to help determine who needs a transplant most urgently. This score, calculated from blood test results including bilirubin, creatinine, and clotting factors, estimates the risk of death within three months and helps prioritize patients on the transplant waiting list. People with higher MELD scores are sicker and receive higher priority for available organs.^[22]

Not everyone with cirrhosis is a candidate for transplantation. Patients must undergo extensive evaluation to ensure they are healthy enough for the surgery and will be able to take the required anti-rejection medications for the rest of their lives. Active alcohol or drug use typically disqualifies patients, as does advanced heart or lung disease and certain cancers.^[13]

Treatment in Clinical Trials

While standard treatments can help manage cirrhosis and slow its progression, researchers continue searching for new therapies that might work better or address aspects of the disease that current treatments cannot. Clinical trials test these experimental approaches in carefully monitored studies before they become widely available.

Understanding Clinical Trial Phases

Clinical trials follow a structured progression through different phases, each designed to answer specific questions. Phase I trials focus primarily on safety, testing a new treatment in a small group of people to determine safe doses and identify side effects. Phase II trials expand to more participants and begin evaluating whether the treatment actually works for its intended purpose, measuring effects on disease markers and symptoms. Phase III trials are large studies comparing the new treatment directly against current standard treatments to see if it offers meaningful improvements. If a treatment proves safe and effective through all these phases, regulatory agencies may approve it for general use.^[28]

Promising Approaches Under Investigation

Several innovative strategies are being explored in clinical trials for cirrhosis. One area of active research involves medications that might reduce liver scarring or even reverse some existing fibrosis. These anti-fibrotic therapies target the cellular processes that create scar tissue in the liver. While no such drugs have yet been approved specifically for cirrhosis, various compounds are being tested in different phases of clinical trials.

For people with MASH-related cirrhosis, researchers are testing several types of medications. Some work as enzyme inhibitors that block specific pathways involved in liver inflammation and fat accumulation. Others target hormones or receptors that regulate metabolism and fat storage. These investigational drugs aim not only to stop further damage but potentially to improve the liver’s condition by reducing fat and inflammation.

Another promising area involves treatments that address portal hypertension, the increased blood pressure in the portal vein that leads to many cirrhosis complications. Beyond existing medications like beta blockers, researchers are investigating new compounds that might more effectively reduce this pressure through different mechanisms. Some experimental drugs target specific molecular pathways that control blood vessel tone and blood flow in the liver.

Researchers are also exploring ways to help the liver regenerate or to support its function while it is damaged. Some studies investigate stem cell therapies or growth factors that might stimulate healthy liver cells to multiply and replace scarred tissue. While still highly experimental, these approaches represent a fundamentally different strategy from current treatments that mainly focus on preventing further damage.

Advanced Procedures and Techniques

The TIPS procedure mentioned earlier continues to be refined in clinical studies. Researchers are testing when it should be used, which patients benefit most, and how to minimize complications like hepatic encephalopathy that sometimes occur after the procedure. Some trials investigate “preemptive TIPS,” placing the shunt early in patients at high risk of serious bleeding rather than waiting until bleeding occurs. Studies suggest this approach may improve survival in carefully selected patients, particularly those with Child-Pugh scores between 10 and 13 points or those with active bleeding seen during endoscopy, though the survival benefit in the latter group still needs further confirmation.^[19]

Participating in Clinical Trials

Clinical trials take place in medical centers around the world, including in the United States, Europe, and other regions. Each trial has specific eligibility criteria that determine who can participate. These criteria might include the cause of cirrhosis, its severity, the presence or absence of complications, and other health factors. Patients interested in clinical trials should discuss the option with their liver specialist, who can help determine whether any suitable studies are available and whether participation might be appropriate.

Participation in clinical trials is always voluntary and involves potential risks and benefits. Patients receive careful monitoring and regular assessments. They may gain early access to promising new treatments, though there is no guarantee these will work better than standard care. All clinical trials must be approved by ethical review boards and follow strict regulations to protect participants’ safety and rights.

Most common treatment methods

• Addressing underlying causes
  • Complete alcohol abstinence for alcohol-related cirrhosis, often with counseling and support programs
  • Direct-acting antiviral medications for hepatitis C, achieving cure rates over 95% in 8-12 weeks
  • Long-term antiviral therapy for hepatitis B to suppress the virus and prevent further damage
  • Weight loss through diet and exercise for metabolic dysfunction-associated steatohepatitis (MASH)
  • Immune-suppressing medications for autoimmune hepatitis
• Managing fluid retention
  • Low-sodium diet limiting salt intake to less than 2 grams daily
  • Diuretic medications to help eliminate excess fluid through urination
• Preventing and treating bleeding
  • Beta-blocker medications to reduce pressure in enlarged blood vessels (varices)
  • Endoscopic procedures to stop active bleeding from varices
  • TIPS (transjugular intrahepatic portosystemic shunt) procedure to create new blood flow pathways
• Managing brain function effects
  • Lactulose medication to remove toxins from the body and prevent hepatic encephalopathy
  • Dietary adjustments and protein management
• Preventing infections
  • Antibiotics to treat or prevent bacterial infections
  • Vaccinations including flu shots and pneumococcal vaccines
• Nutritional support
  • Dietitian-guided meal planning with small, frequent meals throughout the day
  • Adequate protein intake from lean sources to prevent muscle wasting
  • Vitamin and mineral supplementation when deficiencies are identified
• Liver transplantation
  • Surgical replacement of the diseased liver with a healthy donor liver for severe, end-stage disease
  • Prioritization based on MELD score and other factors
  • Lifelong anti-rejection medications after transplant